A Phase I clinical trial to evaluate the safety and efficacy of Natural Vascular Scaffolding (NVS) technology to treat peripheral artery disease (PAD)

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 07 Oct 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Peripheral vascular disorder therapeutics Alucent Biomedical (Primary)
Indications Peripheral arterial disorders; Peripheral vascular disorders
Focus Adverse reactions; First in man; Therapeutic Use
Acronyms ACTIVATE I
Sponsors Alucent Biomedical

01 Oct 2020 Status changed from planning to recruiting, according to an Alucent Biomedical media release.
13 Jan 2020 New trial record
09 Jan 2020 According to an Alucent Biomedical media release, enrollment in this study is expected to begin in Q1 2020. Up to 15 subjects will be enrolled across five research sites, including the Cardiovascular Institute of the South in Houma, La., and the Wellmont Hollston Valley Medical Center in Kingsport, Tenn.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com